Education
About Us
Working with TipRanks
Follow Us
Recordati Industria Chimica e Farmaceutica SPA (IT:REC)
:REC
RESEARCH TOOLSreports
REC Stock Chart & Stats
Day’s Range― - ―
52-Week Range€43.98 - €60.95
Previous CloseN/A
Volume283.52K
Average Volume (3M)379.16K
Market Cap
€10.21B
Enterprise Value€12.73B
Total Cash (Recent Filing)€244.58M
Total Debt (Recent Filing)€992.19M
Price to Earnings (P/E)24.5
Beta0.63
Next Earnings
May 08, 2025EPS EstimateN/A
Next Dividend Ex-Date
May 19, 2025Dividend Yield2.46%
Share Statistics
EPS (TTM)2.02
Shares Outstanding209,125,150
10 Day Avg. Volume215,743
30 Day Avg. Volume379,160
Financial Highlights & Ratios
PEG Ratio3.62
Price to Book (P/B)N/A
Price to Sales (P/S)4.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€54.17Price Target Upside9.52% Upside
Rating ConsensusHold
Number of Analyst Covering3
---
Recordati Industria Chimica e Farmaceutica SPA News
PremiumCompany Announcements
FDA Approves Expanded Use of Recordati’s ISTURISA® for Cushing’s Syndrome
PremiumCompany Announcements
Recordati Discloses Treasury Share Transactions and Buy-Back Program
PremiumCompany Announcements
Recordati Concludes Share Buyback Program
PremiumCompany Announcements
Recordati Publishes Directors’ Report Ahead of Shareholders’ Meeting
---
Options Prices
Currently, No data available
---
Ownership Overview
0.08% Insiders
6.70%
Mutual Funds
― Other Institutional Investors
87.68% Public Companies and
Individual Investors
REC FAQ
What was Recordati Industria Chimica e Farmaceutica SPA’s price range in the past 12 months?
Recordati Industria Chimica e Farmaceutica SPA lowest stock price was €43.98 and its highest was €60.95 in the past 12 months.
What is Recordati Industria Chimica e Farmaceutica SPA’s market cap?
Recordati Industria Chimica e Farmaceutica SPA’s market cap is €10.21B.
When is Recordati Industria Chimica e Farmaceutica SPA’s upcoming earnings report date?
Recordati Industria Chimica e Farmaceutica SPA’s upcoming earnings report date is May 08, 2025 which is in 10 days.
How were Recordati Industria Chimica e Farmaceutica SPA’s earnings last quarter?
Recordati Industria Chimica e Farmaceutica SPA released its earnings results on Feb 13, 2025. The company reported €0.379 earnings per share for the quarter, beating the consensus estimate of N/A by €0.379.
Is Recordati Industria Chimica e Farmaceutica SPA overvalued?
According to Wall Street analysts Recordati Industria Chimica e Farmaceutica SPA’s price is currently Undervalued.
Does Recordati Industria Chimica e Farmaceutica SPA pay dividends?
Recordati Industria Chimica e Farmaceutica SPA pays a Annually dividend of €0.67 which represents an annual dividend yield of 2.46%. See more information on Recordati Industria Chimica e Farmaceutica SPA dividends here
What is Recordati Industria Chimica e Farmaceutica SPA’s EPS estimate?
Recordati Industria Chimica e Farmaceutica SPA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Recordati Industria Chimica e Farmaceutica SPA have?
Recordati Industria Chimica e Farmaceutica SPA has 209,125,150 shares outstanding.
What happened to Recordati Industria Chimica e Farmaceutica SPA’s price movement after its last earnings report?
Recordati Industria Chimica e Farmaceutica SPA reported an EPS of €0.379 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.218%.
Which hedge fund is a major shareholder of Recordati Industria Chimica e Farmaceutica SPA?
Currently, no hedge funds are holding shares in IT:REC
---
Company Description
Recordati Industria Chimica e Farmaceutica SPA
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth strategy. The vast majority of the company's revenue is generated in Italy, followed by France and Germany. Recordati reports two operating segments: specialty and primary care and rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.
---
REC Stock 12 Month Forecast
Average Price Target
€54.17
▲(9.52% Upside)
Technical Analysis
---